Mitigating the Impact of Pandemic (H1N1): Options for Public Health Measures Dr Li Ailan Communicable Disease Surveillance & Response (CSR) WHO Western.

Slides:



Advertisements
Similar presentations
Introduction to Pandemic Influenza
Advertisements

1 ‘School Closing’ as a Potential Means to Counter Pandemic Influenza Table Top Exercise (TTX)
JUNIADEE AHMAD (Acting) Chief Executive Officer Public Relation Division Ministry of Health Brunei Darussalam.
Humanitarian Pandemic Preparedness and Response Phnom Penh 12 October, 2009 Ron Waldman, MD.
Wrap-up of Day 1. Plenary One: Regional and Global Update Update of global situation and response to pandemic (H1N1) Dr Wenqing Zhang Regional.
Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
CDC Meeting on Community Mitigation of Pandemic Influenza Nearly all slides are from Presentations made at the Stakeholders Meeting Community Mitigation.
Communicable Disease Surveillance & Response WHO-WPRO Pandemic (H1N1) 2009 situation and response in the Western Pacific Region Takeshi Kasai Communicable.
Challenges of the 2009 H1N1 Pandemic Influenza: Charles Penn Global Influenza Programme World Health Organization Geneva.
Pandemic Influenza: Role and Responsibility of Local Public Health Richard M. Tooker, MD Chief Medical Officer Kalamazoo County Health and Community Services.
Miriam Nuño Harvard School of Public Health, USA Gerardo Chowell Los Alamos National Laboratory, USA Abba Gumel University of Manitoba, Canada AIMS/DIMACS/SACEMA.
Non-pharmaceutical Interventions to Contain a Pandemic
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
Preparing for the next flu pandemic MINISTRY OF HEALTH SINGAPORE 20 Jan 2006.
Swine Flu update Jacob Kool Communicable Disease Surveillance and Response WHO South Pacific 29 April 2009 WHO/WPRO.
The Quality Management System
20 Answers About Influenza
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
Departmental Perspectives on Viral Hepatitis
Nonpharmaceutical Interventions 1 Emergency hospital during influenza epidemic, Camp Funston, Kansas. National Museum of Health and Medicine.
Capability Cliff Notes Series PHEP Capability 11—Non- Pharmaceutical Interventions What Is It And How Will We Measure It?
Community Mitigation of Pandemic Influenza What Key Stakeholders Need to Know Poudre School District Board of Education November 13, 2007.
From Pandemic Preparedness to Management: UK experience Professor Lindsey Davies CBE FRCP FFPH National Director of Pandemic Influenza Preparedness.
Hot Topic Meeting by: Royal College of Physicians of Edinburgh & The Scottish Executive Health Department Pandemic Flu Planning Scotland’s Health Response.
Tennessee Department of Health Pandemic Influenza Planning David Kirschke, MD Medical Epidemiologist Northeast Tennessee Regional Health Office.
ATP NVAC PIWG Report Pandemic Influenza Antiviral Strategies and Priority Groups Andrew T. Pavia M.D. University of Utah.
1 ‘School Closing’ as a Potential Means to Counter Pandemic Influenza Table Top Exercise (TTX)
Association of Health Care Journalists Preparing Communities For Pandemics Houston, Texas March 18, 2006 Georges C. Benjamin, MD, FACP Executive Director.
Ellen Meyer Senior Manager Global Occupational Health Programs Pandemic Preparedness: Corporate Planning Process.
Stanislaus County It’s Not Flu as Usual It’s Not Flu as Usual Pandemic Influenza Preparedness Renee Cartier Emergency Preparedness Manager Health Services.
Seasonal and H1N1 Flu Guidance on helping Child Care and Early Childhood Programs respond to Influenza Season September 17, 2009 Presented by: Leona Davis.
Rapid Containment: Pharmaceutical Measures (Phase 4 & 5)
Best Practice Guideline for the Workplace During Pandemic Influenza Occupational Health and Safety Employment Standards.
Non-Pharmaceutical Interventions to Face the Pandemic Dr John J. Jabbour Senior Epidemiologist IHR/CSR/DCD WHO/EMRO INTERCOUNTRY MEETING ON AVIAN INFLUENZA.
Lessons from the European Experience with A(H1N1) 2009 Angus Nicoll CBE European Centre for Disease Prevention and Control 3 rd meeting of the National.
HHS Pandemic Influenza Preparedness Planning Julie Louise Gerberding, MD, MPH.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
Health Security and Emergencies Ebola Response 13 October 2014.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
Preparing for a Influenza Pandemic in Utah Robert T. Rolfs, MD, MPH Utah Department of Health December 4, 2006.
Morris County Office of Health Management Community Containment for Disease Toolbox NW New Jersey Region.
ASDPE Asia Pacific Strategy for Emerging Diseases (2010) and Influenza Activities Health Security and Emergencies (DSE) WHO Western Pacific Regional Office.
Update: “New Flu” Activity and Community Mitigation Diane Woolard, PhD, MPH Director, Division of Surveillance and Investigation Virginia Department of.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
CONNECTICUT PANDEMIC PLANNING Meg Hooper, MPA Connecticut Department of Public Health 9 Oct 2008.
US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.
Non-Pharmaceutical Interventions. Session Outline Non-Pharmaceutical Interventions (NPI)  Concept and application  Components and levels of interventions.
Capability Cliff Notes Series PHEP Capability 11—Non- Pharmaceutical Interventions What Is It And How Will We Measure It?
Governor’s Taskforce for Pandemic Influenza Preparedness Issue Paper Credible and Effective Decision-making Workgroup Members Robert Rolfs, State Epidemiologist,
Response to Influenza (H1N1) 2009 in Thailand Dr. Unchalee Siripitayakunkit NVCO, DDC, MoPH 3 rd NIC meeting Yuyang Hotel, Beijing August 19, 2009.
H1N1 Influenza 09 Pandemic Update to State Sporting Associations June 2009.
OBJECTIVES Pandemic Influenza Then and Now Public Health Pandemic Influenza Planning –What to expect –What not to expect Individual/Employee Pandemic.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Training structure Safety and good quality work Module 1: Knowledge about Ebola Virus Disease Support from the community Support from the hospital.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
Australia’s response and activities Rhonda Owen August 2009 PANDEMIC (H1N1) 2009.
Wrap-up Day 2. Plenary Four: Pandemic and avian influenza updates Pandemic H1N1 – Origin of pandemic H1N1 virus – Genetically and antigenically homogenous.
Health Protection Response to Pandemic Influenza in Scotland Dr Martin Donaghy, Health Protection Scotland, 15 th September 2010.
HANIS HANINY MOHD SAID EIZZATI BINTI ARIPIN. OUTSIDE MALAYSIA IN MALAYSIA  Mid March – a new strain of flu virus similar to one seen in pigs was infecting.
INFLUENZA PANDEMIC PREPAREDNESS IN SINGAPORE Developments & Ethical Considerations Communicable Diseases Division Ministry of Health, Singapore.
Current Pandemic H1N1 Updates in the Philippines Department of Health, Philippines Juan M. Lopez, MD, PGradDipPH, MPH Aldrin Q. Reyes, RN.
Pharmacy in Public Health: Levels of Disease Prevention Add course Date here.
PANDEMIC H1N1 IN HANOI-VIETNAM: OVERVIEW AND RESPONSE.
PANDEMIC INFLUENZA M. Rony Francois, MD, MSPH, PhD
Overview of the Objectives, Expected Outcomes, and Meeting Agenda
Annual UW Disaster Exercise
Presentation transcript:

Mitigating the Impact of Pandemic (H1N1): Options for Public Health Measures Dr Li Ailan Communicable Disease Surveillance & Response (CSR) WHO Western Pacific Regional Office (WPRO) 3 rd Meeting of the National Influenza Centres in the Western Pacific and South-East Asia Regions August 2009, Beijing, China

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) OutlineOutline What options are available for public health interventions? What have countries prepared for non-pharmaceutical interventions? What actual public health measures have been applied or being implemented in response to pandemic (H1N1) 2009? Conclusion

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Primary Strategies for Combating Influenza Pharmaceutical interventions –Use of matched vaccines –Use of effective antiviral drugs Non-pharmaceutical interventions Non-pharmaceutical interventions –Individual and household level public health measures –Societal level public health measures, including social distancing

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Goals of Public Health Intervention Delay outbreak peak Delay spread and shift an epidemic curve to the right side –to reduce peak burden on health care facilities (e.g. hospitals) –to “buy time” for other measures (e.g. vaccination) Reduce morbidity and mortality through reducing the total number of cases 1 2 3

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Public Health Measures Available (theoretically) at national and community level 1. Individual/household measures  Personal protective measures  Isolation & quarantine  Infection prevention and control in the home setting  Use of masks in the community setting 2. Societal measures, including social distancing  Suspension of classes and child care programmes  Adjusting or changing work patterns  Restriction of public or mass gatherings  Domestic travel advisories and restrictions 1. Individual/household measures  Personal protective measures  Isolation & quarantine  Infection prevention and control in the home setting  Use of masks in the community setting 2. Societal measures, including social distancing  Suspension of classes and child care programmes  Adjusting or changing work patterns  Restriction of public or mass gatherings  Domestic travel advisories and restrictions

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Public Health Measures Available (theoretically) at the international border 1. International travel and screening  Health advice and alerts to travellers  Health declaration form  Temperature screening  On-board identification of suspected travellers  International travel advisory, restriction, border closure? 2. Management of symptomatic & exposed travellers  Symptomatic travellers (isolation & treatment…)  Exposed travellers (quarantine…) 1. International travel and screening  Health advice and alerts to travellers  Health declaration form  Temperature screening  On-board identification of suspected travellers  International travel advisory, restriction, border closure? 2. Management of symptomatic & exposed travellers  Symptomatic travellers (isolation & treatment…)  Exposed travellers (quarantine…)

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Key considerations Decision on public health measures based on risk assessment, especially severity and potential impact Public health measures should be evidence-based whenever possible Countries should balance the benefits against the costs and potential consequences Need to be tailored to suit country or local context Planning, coordination and communication is essential

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Comparative risk of outbreaks Transmissibility Low High High Low Severity of Disease (Morbidity & Mortality) H5N1 SARS 1918 Pandemic Pandemic (H1N1) 2009? Seasonal Flu

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Possible strategies based on risk category Transmissibility Low High  Aiming at rapid containment at the early stage, and mitigating the impacts, if containment not possible  Aiming at preventing disease importation and containing the virus High Low Severity of Disease (Morbidity & Mortality)  Aiming at reducing transmission and mitigating impact with focus on vulnerable population  Routine public health measures without additional aggressive interventions

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Matching cost and consequences of interventions with risk level Cost s and Consequences Level of Risk More acceptable interventions Less acceptable interventions SARS Seasonal Influenza New H1N1 ??? 1918 pandemic virus or worse E.g. Isolation & quarantine E.g. Travel restriction E.g. Respiratory hygiene FB A C E D

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Options for interventions: Decision Matrix Decision (Yes/No/wait) Limitations & consequence BenefitsOptions high social & economic cost Second consequences Need alternative childcare programme Absenteeism of working parents, including HCWs Educational continuity? Reducing transmission among children and decreasing spread to the community Acceptable in some countries School closure Comments & guidance: -Must weight the benefits of reducing transmission against economic and social costs -Decision based on local situation and context (“case-by-case”)… -…

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Pandemic Preparedness Assessment 2009 Annual assessment of pandemic preparedness was conducted in May-June, using the WHO WPRO and CDC Joint Assessment Tool A supplementary questionnaire on public health measures was added in this “readiness” survey –Is this public health measure included in your national response plan? –Did you apply or consider applying this measure? –What is your trigger to start and stop the public health intervention? The questionnaire was distributed to collect data from 17 countries and areas, 15 (88%) responded to the survey

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Pandemic Preparedness Assessment 2009: Public Health Measures at International Borders

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Pandemic Preparedness Assessment 2009: Individual/Household level Measures

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Pandemic Preparedness Assessment 2009: Societal level Measures

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Responding to Pandemic (H1N1) 2009 Based on risk assessment, most countries with community transmission have shifted from “containment” efforts to “mitigation” strategies Robust risk assessment help ensure appropriate public health measures are planned and implemented. Public health interventions have been dynamic in the region with most countries and areas implemented –relatively “aggressive” border measures including passengers’ screening –personal hygiene behaviour interventions –school closures at the early stage of outbreaks

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Example: School closure At the early stage of Pandemic (H1N1) 2009, the large proportion of school children and young adults affected School closure measure has been most frequently used as compared with other social level measures Many countries used school closure measures in the Asia Pacific Region, including Australia, China, Japan, Malaysia, New Zealand, the Philippines, Singapore and Thailand… Types of measures varied: from “real” school closure or class dismissal, from “proactive” or “reactive” approach… Length of closure Length of closure varied: mostly 7-14 days

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) School closure in Japan (May 2009) 17 May : Schools closed, in Osaka 17 May: Schools closed Hyogo Prefecture Source: NIID, Japan

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) School closure in Japan (June 2009) Schools and Kindergartens in Fukuoka were closed on 7 June Source: NIID, Japan

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Conclusion The potential benefits of public health measures should be carefully balanced against their potentially significant social and economic costs – “one size will not fit all” Decision based on assessed situation and local context. No standard, single combination of measures will fit all countries – “one size will not fit all” Available information indicated some public health measures have helped slow down the spread of the virus Need for continuing planning, monitoring and evidence

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Interim guidance available Mitigating the impact of pandemic (H1N1) 2009: Options for public health measures Responding to pandemic (H1N1) 2009: Options for interventions at international points of entry h_guidance.htm h_guidance.htm

Communicable Disease Surveillance and Response (CSR) WHO Western Pacific Regional Office (WPRO) Acknowledgement  Dr Takeshi Kasai, Regional Advisor, CSR/WPRO  Dr Nobuhiko Okabe, NIID, Japan  Ms Qiu Yi Khut, CSR/WPRO  Ms Katie Harrigan, CSR/WPRO